ACRYSOF IQ NATURAL SINGLEPIECE IOL
Report
- Report Number
- 9612169-2019-00087
- Event Type
- Injury
- Date Received
- May 6, 2019
- Date of Event
- December 5, 2018
- Report Date
- September 6, 2019
- Manufacturer
- ALCON LABORATORIES IRELAND LTD.
- Product Code
- HQL
- PMA / PMN Number
- P930014
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- 003
Narratives
THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
EVALUATION SUMMARY: THE PRODUCT WAS RETURNED FOR ANALYSIS AND THE REPORTED COMPLAINT WAS NOT OBSERVED. THE IOL WAS DAMAGED AND THIS DAMAGE WAS NOT MENTIONED BY THE CUSTOMER. ADDITIONAL OBSERVATIONS WERE AS FOLLOWS: ONLY ONE SEGMENT OF IOL RETURNED ADHERED TO A GAUZE INSIDE A ZIP LOCK BAG. A SIGNIFICANT AMOUNT OF SOLUTION IS DRIED ON BOTH SURFACES OF THE SEGMENT AND ONE HAPTIC. THE OPTIC IS SPLIT/CUT DIVIDING THE IOL IN SEGMENTS. OPTICAL POWER & RESOLUTION COULD NOT BE VERIFIED DUE TO THE EXTENSIVE OPTIC DAMAGE. NO ROOT CAUSE IDENTIFIED AS THE REPORTED COMPLAINT "EXPLANTED DUE TO DISLOCATED LENS" COULD NOT BE OBSERVED. THE RETURNED IOL SHOWS EVIDENCE OF POSSIBLE HANDLING BY THE CUSTOMER DUE TO THE PRESENCE OF SOLUTION AND HOW IT WAS RETURNED SPLIT/CUT DIVIDED IN SEGMENTS. THE LENS WAS CUT IN HALF THROUGH THE CENTER OF THE OPTIC. DUE TO THIS DAMAGE, A FUNCTIONAL TEST (LENS BENCH) TO CHECK THE POWER AND RESOLUTION OF THE LENS COULD NOT BE CONDUCTED. AN IMPACT TO THE VISUAL ACUITY OF THE PATIENT CANNOT BE VERIFIED BY EXAMINATION OF THE RETURNED PRODUCT. IN ADDITION TO THIS, ALL IOLS ARE 100% COSMETICALLY INSPECTED AS PER APPROVED MANUFACTURING PROCEDURES AND THE REPORTED LENS DAMAGE WOULD NOT MEET OUR CURRENT RELEASE CRITERIA. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
ADDITIONAL INFORMATION WAS PROVIDED INDICATING THAT ON THE FIRST POSTOPERATIVE DAY THERE WAS 1+ FLARE AND CELL IN THE ANTERIOR CHAMBER. APPROXIMATELY 3 MONTHS LATER, THERE WAS NO IMPROVEMENT IN VISION, K SCARRING, THE IOL WAS IN GOOD POSITION, 1+ POSTERIOR CAPSULE OPACITY AND TRACE EPIRETINAL MEMBRANE. APPROXIMATELY 2 YEARS LATER, THE PATIENT'S RIGHT EYE WAS RED WITH PAIN AND THE VISION HAD DECREASED TO UCVA HAND MOTION. THE IOP INCREASED TO 59. THE ANTERIOR CHAMBER HAD 4+ INFERIOR HEMORRHAGE, IRIS NEOVASCULARIZATION, THE IOL WAS IN GOOD POSITION. THE PATIENT WAS DIAGNOSED WITH SEVERE NEOVASCULAR GLAUCOMA, VITREOUS HEMORRHAGE, EPIRETINAL MEMBRANE PUCKER, AGE RELATED MACULAR DEGENERATION. THE PATIENT WAS STARTED ON MEDICATION. APPROXIMATELY 3 MONTHS LATER B-SCAN RESULTS REFLECT A VITREOUS HEMORRHAGE - IOL MAYBE RUBBING ON IRIS. THE FOLLOWING DAY THE IOL WAS OBSERVED AS DISLOCATED WITH A HYPHEMA. THE IOL WAS REMOVED AND REPLACED WITH A DIFFERENT LENS MODEL 2 WEEKS LATER.
EVALUATION SUMMARY: THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. THE PRODUCT HISTORY AND BATCH RECORDS WERE REVIEWED AND DOCUMENTATION INDICATED THE PRODUCT MET RELEASE CRITERIA. THE PRODUCT INVESTIGATION COULD NOT IDENTIFY A ROOT CAUSE. THERE HAVE BEEN NO OTHER COMPLAINTS REPORTED IN THE LOT NUMBER. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
A FACILITY REPRESENTATIVE REPORTED THAT APPROXIMATELY 2 YEARS FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED DECREASED VISION FOR 1 MONTH. THE IOL DISLOCATED, RUBBED ON IRIS CAUSING HYPHEMA AND A VITREOUS HEMORRHAGE. THERE WAS NO INDICATION OF TRAUMA. THE IOL WAS EXCHANGED FOR A DIFFERENT LENS MODEL AND ONE DIOPTER DIFFERENCE IN POWER. THE PATIENT'S VISION IS STABLE AND DOING WELL POST THE EXCHANGE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 374968 | ACRYSOF IQ NATURAL SINGLEPIECE IOL | INTRAOCULAR LENS | HQL | ALCON LABORATORIES IRELAND LTD. | SN60WF | 21150423 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Required Intervention |